Dr Sean Gill and Dr Chetan Mukhtyar (Norfolk and Norwich University Hospital, UK) discuss the efficacy of tocilizumab for GCA, based on a 12-month extension of Stone et al.’s landmark clinical trial. Dr Mukhtyar provides an overview of the trial, including key findings, limitations, and implications for clinical practice. Read the paper: https://doi.org/10.1093/rheumatology/keab418Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, or tweet us @RheumJnl. Want to read more of our research? Explore Rheumatology and Rheumatology Advances in Practice.